ROBITUSSIN DIRECT Trademark

Trademark Overview

On Thursday, February 10, 2022, a trademark application was filed for ROBITUSSIN DIRECT with the United States Patent and Trademark Office. The USPTO has given the ROBITUSSIN DIRECT trademark a serial number of 97261556. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 30, 2024. This trademark is owned by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The ROBITUSSIN DIRECT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cold, cough and flu symptoms
robitussin direct

General Information

Serial Number97261556
Word MarkROBITUSSIN DIRECT
Filing DateThursday, February 10, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cold, cough and flu symptoms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHALEON US HOLDINGS LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19808
Party NameGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808
Party NameGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Trademark Events

Event DateEvent Description
Monday, February 14, 2022NEW APPLICATION ENTERED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 17, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 23, 2022ASSIGNED TO EXAMINER
Saturday, November 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 24, 2023SOU EXTENSION 1 GRANTED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 24, 2023SOU EXTENSION 1 FILED
Thursday, February 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, August 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 21, 2024SOU EXTENSION 2 GRANTED
Thursday, February 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, February 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 21, 2024SOU EXTENSION 2 FILED
Monday, September 30, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 30, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

direct robitussin cough symptoms cold treatment preparations pharmaceutical